FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes - PR Newswire (press release)

FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes PR Newswire (press release) SILVER SPRING, Md., Dec. 11, 2017 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric ... and more »

from Health - Google News http://ift.tt/2Bg5cKG